CollPlant Biotechnologies Ltd. (CLGN)

Market Closed

17 Jul, 20:00

NASDAQ (NMS)

0. 34

-0

-1.1799%

4.73M Market Cap

- P/E Ratio

- Div Yield

23,000 Volume

-1.42 Eps

$ 0.34

Previous Close

Investors:

Add Transaction

Day Range

0.32 0.35

Year Range

0.27 3.23

Want to track CLGN and more in your Portfolio? 🎯

Get Started For Free

CollPlant Biotechnologies Ltd. (CLGN) Q4 2024 Earnings Call Transcript

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN ) Q4 2024 Earnings Conference Call March 26, 2025 10:00 AM ET Company Participants Dory Kurowski - LifeSci Advisors Yehiel Tal - CEO Eran Rotem - Deputy CEO and CFO Conference Call Participants Swayampakula Ramakanth - H.C.

Seekingalpha | 1 year ago

CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Transcript

CollPlant Biotechnologies Ltd (NASDAQ:CLGN ) Q3 2024 Earnings Conference Call November 27, 2024 10:00 AM ET Company Participants Dory Kurowski - LifeSci Advisors Yehiel Tal - CEO Eran Rotem - Deputy CEO and CFO Operator Greetings, and welcome to the CollPlant Biotechnologies Third Quarter 2024 Earnings Call. At this time all participants are in a listen-only mode.

Seekingalpha | 1 year ago

CollPlant (CLGN), Stratasys Initiate Study for Breast Implants

CollPlant (CLGN) and Stratasys announce the initiation of a pre-clinical study to focus on the ability of implants to grow natural breast tissue and completely degrade over time.

Zacks | 1 year ago

CollPlant Biotechnologies Ltd. (CLGN) Q2 2024 Earnings Call Transcript

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN ) Q2 2024 Earnings Conference Call August 20, 2024 10:00 AM ET Company Participants Dan Ferry - LifeSci Advisors Yehiel Tal - CEO Eran Rotem - Deputy CEO and CFO Conference Call Participants Sean Lee - H.C.

Seekingalpha | 1 year ago

Blog Affiliate Program About Terms Privacy Help Contact Us